Prosthesis size and long-term survival after aortic valve replacement

Slides:



Advertisements
Similar presentations
Tomislav Mihaljevic, MD, Edward R
Advertisements

Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine 
Characterization and Importance of Air Leak After Lobectomy
Robert J. Dabal, MD, James K
Generating New Knowledge in Cardiac Interventions
Advising complex patients who require complex heart operations
Should lung transplantation be performed for patients on mechanical respiratory support? The US experience  David P. Mason, MD, Lucy Thuita, MS, Edward.
Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H
Determinants of repair type, reintervention, and mortality in 393 children with double- outlet right ventricle  Timothy J. Bradley, MD, Tara Karamlou,
Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation?  Tara Karamlou, MD, Eugene.
Effect of changes in postoperative spirometry on survival after lung transplantation  David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,
Endovascular versus open elephant trunk completion for extensive aortic disease  Eric E. Roselli, MD, Sreekumar Subramanian, MD, Zhiyuan Sun, BS, Jahanzaib.
Surgical treatment of pseudoaneurysm of the thoracic aorta
Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysm
Factors influencing early and late outcome of the arterial switch operation for transposition of the great arteries  Gil Wernovsky, MD* (by invitation),
Mauro Lo Rito, MD, Tamadhir Gazzaz, MD, Travis J. Wilder, MD, Rachel D
Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome  Soren Schenk, MD, Patrick M. McCarthy,
Reoperation After Mitral Valve Repair for Degenerative Disease
Bruce W. Lytle, MD, Eugene H. Blackstone, MD, Joseph F
Sina Ercan, MD, Thomas W. Rice, MD, Sudish C. Murthy, MD, PhD, Lisa A
Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes.
Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization  Suresh Keshavamurthy, MBBS, MS, Colleen.
Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair  Douglas R. Johnston, MD, A. Marc Gillinov, MD,
Surgical management of competing pulmonary blood flow affects survival before Fontan/Kreutzer completion in patients with tricuspid atresia type I  Travis.
Clinical-Pathologic Conference: Use and choice of statistical methods for the clinical study, “Superficial adenocarcinoma of the esophagus”  Eugene H.
Appropriate patient selection or health care rationing
Albert S. Y. Chang, MD, Nicholas G. Smedira, MD, Catherine L
Too High for Transplantation
Outcomes of heart transplantation in children with hypoplastic left heart syndrome previously palliated with the Norwood procedure  Bahaaldin Alsoufi,
Charles M. Wojnarski, MD, Lars G. Svensson, MD, PhD, Eric E
Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine 
Does a similar procedure result in similar survival for women and men undergoing isolated coronary artery bypass grafting?  Tamer Attia, MD, MSc, Colleen.
Aortic valve replacement: Is valve size important?
Mechanical valves versus the Ross procedure for aortic valve replacement in children: Propensity-adjusted comparison of long-term outcomes  Bahaaldin.
A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R
Challenging allograft use for aortic valve infective endocarditis: Is it the allograft or the surgeon?  Syed T. Hussain, MD, Eugene H. Blackstone, MD,
William G. Williams, MDa, Jan M. Quaegebeur, MDb, John W
Atrial fibrillation complicating lung cancer resection
Long-Term Durability of Bicuspid Aortic Valve Repair
A. Marc Gillinov, MD, Patrick M. McCarthy, MD, Eugene H
Reduced survival in women after valve surgery for aortic regurgitationEffect of aortic enlargement and late aortic rupture  Monica L. McDonald, MDa, Nicholas.
Biventricular strategies for neonatal critical aortic stenosis: High mortality associated with early reintervention  Edward J. Hickey, MD, Christopher.
Nicholas G. Smedira, MD, Katherine J. Hoercher, RN, Dustin Y
Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L
Superficial adenocarcinoma of the esophagus
Eugene H. Blackstone, MDa,b, Bruce W. Lytle, MDb 
Distal aortic interventions after repair of ascending dissection: The argument for a more aggressive approach  Eric E. Roselli, MD, Gabriel Loor, MD,
Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer  Malcolm M DeCamp, MD, Thomas W Rice, MD, David J Adelstein,
Edward R. Nowicki, MD, MS, Gösta B. Pettersson, MD, PhD, Nicholas G
Two internal thoracic artery grafts are better than one
Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years  Charles A. Yankah, MD, PhD, Miralem Pasic, MD,
Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration.
Long-term effectiveness of operations for ascending aortic dissections
Bahaaldin Alsoufi, MD, Cedric Manlhiot, BSc, Brian W
Intermediate survival in neonates with aortic atresia: A multi-institutional study  Marshall L. Jacobs, MD, Eugene H. Blackstone, MD, Leonard L. Bailey,
Mohammed A Quader, MD, Patrick M McCarthy, MD, A
Is repair preferable to replacement for ischemic mitral regurgitation?
Joseph F. Sabik, MD, Gabriel Olivares, MD, Sajjad Raza, MD, Bruce W
Douglas R. Johnston, MD, Edward G
Endocarditis after mitral valve repair
Turki B. Albacker, MD, MSc, Eugene H. Blackstone, MD, Sarah J
Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis  Michael K Banbury, MD, Delos M Cosgrove,
Mitral valve repair with aortic valve replacement is superior to double valve replacement  A.Marc Gillinov, MD, Eugene H Blackstone, MD, Delos M Cosgrove,
Siva Raja, MD, PhD, Jay J. Idrees, MD, Eugene H
Arvind K. Agnihotri, MD (by invitation), David C
Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: Implications for transcatheter aortic valve replacement 
A. Marc Gillinov, MD, Jon Sirak, MD, Eugene H
Identifying risk factors: Challenges of separating signal from noise
Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter?  Asvin M. Ganapathi,
Richard J Kaplon, MD, Delos M Cosgrove, MD, A
Presentation transcript:

Prosthesis size and long-term survival after aortic valve replacement Eugene H Blackstone, MD, Delos M Cosgrove, MD, W.R.Eric Jamieson, MD, Nancy J Birkmeyer, PhD, John H Lemmer, MD, D.Craig Miller, MD, Eric G Butchart, FRCS, Giulio Rizzoli, MD, Magdi Yacoub, MD, Akiko Chai, MS  The Journal of Thoracic and Cardiovascular Surgery  Volume 126, Issue 3, Pages 783-793 (September 2003) DOI: 10.1016/S0022-5223(03)00591-9

Figure 1 Cumulative distribution of physical internal valve orifice dimension referenced to patients’ BSA (prosthesis-patient size). Distribution is stratified according to variety of prosthesis: mechanical, stented bovine pericardial (pericardial), stented porcine xenograft (porcine), and allograft. For orientation, median size is value on horizontal axis that corresponds to value of 50% on vertical axis; half the sizes were smaller than this and half larger. Value on horizontal axis corresponding to 10% on vertical axis is the 10th percentile, meaning that 10% of valves were smaller than this and 90% larger. A, Indexed orifice area. B, Standardized orifice size. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Figure 2 Overall survival after AVR. A, Survival. Parametric estimates (solid line) are enclosed within confidence limits equivalent to 1 SE (68%). Numbers in parentheses represent numbers of patients still being followed at 1, 5, 10, and 15 years. Faintly visible at these same intervals are vertical bars representing confidence limits for corresponding nonparametric Kaplan-Meier estimates. B, Hazard function (instantaneous risk of death). Solid curve enclosed within asymmetric 68% confidence limits represents parametric overall hazard estimates. Individual hazard components are labeled early, constant, and late; they sum to yield overall hazard. Rapidly falling early phase of risk lasted approximately 6 months (short-term survival), was dominated by operative mortality, and had effective statistical power of 774 events. Constant hazard phase across all time dominated between 6 months and 5 years (intermediate-term survival) and had statistical power of 1654 events. Late hazard phase, rising steadily from time zero, dominated beyond 5 years (late-term survival) and had statistical power of 1470 events. Variables in multivariable analyses modulated area beneath early hazard phase, raised or lowered constant hazard, and tilted late hazard component. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Figure 3 Non–risk-adjusted survival and indexed orifice area. A, Time-related survival stratified by indexed orifice area. B, Kaplan-Meier estimates of 1-, 5-, and 10-year survivals in finely grouped strata of indexed orifice area. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Figure 4 Non–risk-adjusted survival and standardized orifice size (Z). A, Time-related survival stratified by Z. B, Kaplan-Meier estimates of 1-, 5-, and 10-year survivals in finely grouped strata of Z. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Figure 5 Magnitude and shape of effect of continuous prosthesis-patient size on 30-day and 1-, 5-, 10-, and 15-year survivals. Depictions are nomograms of multivariable equations solved for a typical patient with aortic stenosis (see Methods) with valve size varied. A, Indexed orifice area. B, Standardized orifice size. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Figure 6 Magnitude and shape of effect of continuous prosthesis-patient size on 30-day mortality. Depictions are nomograms of multivariable equations solved for a typical patient with aortic stenosis (see Methods) with valve size varied. A, Indexed orifice area. B, Standardized orifice size. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Figure 7 Minimum internal prosthesis orifice size necessary to achieve indexed orifice area of at least −1 (1.6 cm2/m2), −2 (1.3 cm2/m2), and −2.5 (1.2 cm2/m2) SDs (Z) below mean normal aortic valve size. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Appendix Figure 1 Non–risk-adjusted survival. A, Stratified by labeled size. B, Stratified by variety of aortic prosthesis inserted: allograft, mechanical, stented bovine pericardial (pericardial), or stented porcine xenograft (porcine). The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)

Appendix Figure 2 Non–risk-adjusted survival stratified by age group. Of 1685 patients 50 years old or younger, 1065 were alive and traced at 5 years, 539 at 10 years, and 160 at 15 years. Of 8224 between 50 and 75 years old, 4010 were alive and traced at 5 years, 1725 at 10 years, and 303 at 15 years. Of 2636 who were 75 years old or older; 698 were alive and traced at 5 years, 140 at 10 years, and 10 at 15 years. For each age group, age-, race-, and ethnicity-matched population life table curve is shown as dot-dash line. Note that younger patients show more marked departure from normal life expectancy. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 783-793DOI: (10.1016/S0022-5223(03)00591-9)